 antagon serotonin receptor ondansetron prevent nausea emesi cyclophosphamide-contain chemotherapi control nausea emesi cancer patient chemotherapi signific manag problem random double-blind placebo-control studi effect serotonin receptor blockad ondansetron GR prevent nausea vomit cyclophosphamide-contain chemotherapi cyclophosphamid dose ondansetron intraven IV mg/kg patient cancer cyclophosphamid combin doxorubicin patient fluorouracil patient adriamycin doxorubicin adria columbu OH methotrex placebo-tr patient patient ondansetron vomit median nausea score mm ondansetron mm placebo seventi percent patient ondansetron normal appetit placebo patient advers event placebo patient ondansetron patient diarrhea headach common event placebo group extrapyramid reaction signific biochem chang placebo-tr patient result serotonin receptor antagonist novel effect safe mode therapi nausea emesi cyclophosphamide-contain chemotherapi addit observ compat view serotonin receptor nausea emesi occur cyclophosphamid chemotherapi